PoshanSense
Food & weight · 4 min read

Do meal-replacement shakes help with weight loss? The programme matters more than the packet

The UK DROPLET trial found greater one-year weight loss with a supervised total-diet-replacement programme. It did not test an ordinary protein shake or an unsupported crash diet.

A plain unbranded meal-replacement drink beside a weekly meal planner and a balanced plate on a soft blue desk.
Original programme illustration; not a product endorsement or personal weight-loss forecast.

Research explained · Published 2018

A shake is easy to photograph and sell. A year-long programme is harder to fit on the label. That difference matters when a weight-loss headline makes the product seem responsible for everything that happened in a trial.

What did the trial demonstrate?

In the UK DROPLET trial, a supported total-diet-replacement programme produced greater average weight loss at one year than usual primary-care support. The average losses were about 10.7 kg and 3.1 kg respectively; the adjusted difference was about 7.2 kg.

Those are group results, not an individual forecast. Some people lost more, some less, and not everyone had a one-year measurement. The trial tells us that offering this programme can work in the studied setting, rather than that a packet guarantees a particular result.

What came with the products?

The intervention used nutritionally complete formula foods as a temporary total diet replacement. It included weekly behavioural support, a planned return to ordinary food and further follow-up contact.

A clinician reviewed relevant medicines at the start and during the early programme. This mattered because a substantial dietary change can affect the safety of existing treatment. The research regimen is not a do-it-yourself recipe.

Usual care involved nurse-led weight-management advice, but did not match the intervention's contact and structure. The trial therefore compared programmes, not two identical programmes differing only in whether someone drank a shake.

Original explanatory infographic

The tested intervention was a whole programme

01

Products

Nutritionally complete total diet replacement, not any protein shake.

02

Support

Regular behavioural contact and planned food reintroduction.

03

Safety

Medication review and adverse-event monitoring.

04

Outcome

Greater average weight loss at one year, with variation and missing follow-up.

DROPLET does not support copying a low-energy research regimen without clinical support.

Is an ordinary protein shake equivalent?

No. A protein drink is designed around a particular nutrient. A total-diet-replacement product is intended to provide a broader nutritional package within a planned programme. Labels, intended use and clinical context differ.

Adding a drink on top of usual meals also asks a different question from replacing intake within a supported intervention. The DROPLET result cannot be attached to every smoothie, supplement or meal marketed for slimming.

Price and convenience matter too, but the paper does not settle whether a commercial programme is the best choice for every household. Access to support and an eating pattern that can be maintained after the intervention remain part of the decision.

What about side effects and keeping weight off?

Any adverse event was reported more often in the total-diet-replacement group: about 51% versus 30%. Common reports included constipation, fatigue, headache and dizziness. Moderate or severe events were not clearly more frequent, but that does not make the programme risk-free.

Some weight returned after the earlier six-month measurement. The one-year result still favoured the intervention, but it does not establish lifelong maintenance. The transition back to food is part of the story, rather than an optional detail.

Nor did every health measure improve clearly. Some blood-pressure and lipid results were uncertain at one year. Greater weight loss is not proof that this trial prevented heart attacks or eliminated future illness.

Who can use this evidence?

Participants were adults with obesity seeking help in UK primary care, predominantly White British, with an average BMI around 37. The results do not provide instructions for children, pregnancy, people at lower weights or every clinical condition.

If considering a restrictive programme, obtain appropriate professional advice about suitability, nutrition and medicine management. An online article cannot perform the assessment used around a clinical intervention.

Our low-fat versus low-carbohydrate explainer covers a different route to changing an eating pattern. Comparing options means comparing the whole intervention and its sustainability, not just a single ingredient.

The useful answer is that supported total diet replacement can help some adults lose weight. The supervision, completeness, support and return to ordinary food are essential parts of the evidence behind that statement.

Evidence context: funding came from Cambridge Weight Plan and UK public research support. The company was reported not to have access to trial data or a role in design, analysis or writing. Educational information; not clinically reviewed.

Sources & further reading

  1. UK · DROPLET primary-care trial (2018)

Study years differ from this article’s publication date. We reviewed full primary papers and relevant supporting material; access limitations are kept out of efficacy claims. Original illustrations and diagrams; no publisher figures reproduced. Educational writing, not clinical review.

Published 11 October 2026 · Sources checked 11 October 2026. Suggest a correction.